Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Diseases of the Thyroid

Free Subscription Articles published in Eur J Endocrinol Retrieve available abstracts of 96 articles: HTML format

Single Articles

May 2023
1. LEBBINK CA, Bresters D, Tersteeg JPB, van den Bos C, et al
   Changes in thyroid function parameters three months after allogenic and autologous hematopoietic stem cell transplantation in children.
   Eur J Endocrinol. 2023 May 26:lvad058. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. CIAMPI R, Ramone T, Romei C, Casalini R, et al
   NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas.
   Eur J Endocrinol. 2023 May 22:lvad051. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2023
3. POPPE KG, Frommer L, Hatun B, Autin C, et al
   Ovarian Stimulation Does Not Induce Thyrotropin Receptor Autoantibodies in Women with Thyroid Autoimmunity.
   Eur J Endocrinol. 2023 Mar 30:lvad045. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2023
4. D'ANDREA G, Gal J, Mandine L, Dassonville O, et al
   Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules.
   Eur J Endocrinol. 2023 Feb 17:lvad017. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. RAZVI S, Jabbar A, Addison C, Vernazza J, et al
   Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment.
   Eur J Endocrinol. 2023 Feb 8:lvad016. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2023
6. COERTS HI, de Keizer B, Marlowe RJ, Verburg FA, et al
   Recombinant or endogenous TSH for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies.
   Eur J Endocrinol. 2023 Jan 19:lvad006. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. MELO M, Ventura M, Cardoso L, da Rocha AG, et al
   Noninvasive follicular thyroid neoplasm with papillary like nuclear feature (NIFTP): clinical, pathological and molecular update 5 years after the nomenclature revision.
   Eur J Endocrinol. 2023 Jan 19:lvad004. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. CENSI S, Manso J, Mian C
   Other markers of medullary thyroid cancer, not only calcitonin.
   Eur J Endocrinol. 2023;188:lvac009.
   PubMed     Abstract available
   
   
   
9. DA SILVA TN, Rodrigues R, Saramago A, Pires C, et al
   Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study.
   Eur J Endocrinol. 2023;188:lvac011.
   PubMed     Abstract available
   
   
   
10. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
    Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
    Eur J Endocrinol. 2023;188:lvac018.
    PubMed     Abstract available
    
    
    December 2022
11. 
    Erratum to: "Adenylate cyclase stimulation and [3H]thymidine incorporation in human thyroid tissues and thyrocyte cultures: The effect of IgG preparation from patients with different thyroid disorders".
    Eur J Endocrinol. 2022;187:X5.
    PubMed    
    
    
    October 2022
12. FOURNEAUX R, Reynaud R, Mougel G, Castets S, et al
    IGSF1 MUTATIONS ARE THE MOST FREQUENT GENETIC AETIOLOGY OF THYROTROPIN DEFICIENCY.
    Eur J Endocrinol. 2022 Oct 1. pii: EJE-22-0520. doi: 10.1530/EJE-22-0520.
    PubMed     Abstract available
    
    
    
13. PRETE A, Gambale C, Cappagli V, Bottici V, et al
    Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib.
    Eur J Endocrinol. 2022 Oct 1. pii: EJE-22-0643. doi: 10.1530/EJE-22-0643.
    PubMed     Abstract available
    
    
    September 2022
14. RODRIGUEZ-RODERO S, Morales-Sanchez P, Tejedor JR, Coca-Pelaz A, et al
    Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers.
    Eur J Endocrinol. 2022;187:335-347.
    PubMed     Abstract available
    
    
    
15. SALTIKI K, Simeakis G, Karapanou O, Alevizaki M, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives.
    Eur J Endocrinol. 2022;187:R53-R63.
    PubMed     Abstract available
    
    
    
16. LE MOAL J, Chesneau J, Goria S, Boizeau P, et al
    Spatiotemporal variation of childhood hyperthyroidism: a 10-year nationwide study.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0355. doi: 10.1530/EJE-22-0355.
    PubMed     Abstract available
    
    
    
17. ALWAN H, Villoz F, Feller M, Dullaart RPF, et al
    Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0523. doi: 10.1530/EJE-22-0523.
    PubMed     Abstract available
    
    
    August 2022
18. REICHERT AD, Nies M, Tissing WJE, Muller-Kobold AC, et al
    Progressive Diastolic Dysfunction in Survivors of Pediatric Differentiated Thyroid Carcinoma.
    Eur J Endocrinol. 2022 Aug 1. pii: EJE-22-0094. doi: 10.1530/EJE-22-0094.
    PubMed     Abstract available
    
    
    July 2022
19. BUFFET C, Allard L, Guillerm E, Ghander C, et al
    Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of Dabrafenib and Trametinib in unresectable anaplastic thyroid carcinoma.
    Eur J Endocrinol. 2022 Jul 1. pii: EJE-22-0366. doi: 10.1530/EJE-22-0366.
    PubMed     Abstract available
    
    
    
20. STEWARDSON P, Eszlinger M, Paschke R
    Usefulness of Genetic Testing of Fine Needle Aspirations for Diagnosis of Thyroid Cancer.
    Eur J Endocrinol. 2022 Jul 1. pii: EJE-21-1293. doi: 10.1530/EJE-21-1293.
    PubMed     Abstract available
    
    
    June 2022
21. UELAND HO, Ueland GA, Lovas K, Breivik L, et al
    Novel Inflammatory Biomarkers in Thyroid Eye Disease.
    Eur J Endocrinol. 2022 Jun 1. pii: EJE-22-0247. doi: 10.1530/EJE-22-0247.
    PubMed     Abstract available
    
    
    
22. SKOV J, Kuja-Halkola R, Magnusson PKE, Gudbjornsdottir S, et al
    Shared etiology of type 1 diabetes and Hashimoto's thyroiditis: a population-based twin study.
    Eur J Endocrinol. 2022;186:677-685.
    PubMed     Abstract available
    
    
    May 2022
23. PETERS C, Schoenmakers N
    The Pathophysiology of transient congenital hypothyroidism.
    Eur J Endocrinol. 2022 May 1. pii: EJE-21-1278. doi: 10.1530/EJE-21-1278.
    PubMed     Abstract available
    
    
    April 2022
24. LEBBINK CA, de Vries LH, Borel Rinkes IHM, Braat AJAT, et al
    FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels.
    Eur J Endocrinol. 2022 Apr 1. pii: EJE-22-0072. doi: 10.1530/EJE-22-0072.
    PubMed     Abstract available
    
    
    March 2022
25. RICHA C, Haidar H, Dupeux M, Papon JF, et al
    Parathyroid hormone in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients.
    Eur J Endocrinol. 2022;186:489-501.
    PubMed     Abstract available
    
    
    
26. NIES M, Arts EGJM, Cantineau AEP, Links TP, et al
    Response to comment on long-term male fertility after treatment with radioactive iodine for DTC.
    Eur J Endocrinol. 2022;186:L9.
    PubMed    
    
    
    
27. GIORDANO D, Botti C, Piana S, Castellucci A, et al
    Hemithyroidectomy and ipsilateral central neck dissection for T1 low-risk papillary thyroid cancer: single-institution retrospective observational study.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0813. doi: 10.1530/EJE-21-0813.
    PubMed     Abstract available
    
    
    
28. JAVAID U, Kennedy D, Addison C, Tsatlidis V, et al
    Frequency, Determinants and Costs of Thyroid Function Testing in a Laboratory serving a large Population.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1172. doi: 10.1530/EJE-21-1172.
    PubMed     Abstract available
    
    
    
29. KIM M, Kim H, Park S, Joo J, et al
    Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1208. doi: 10.1530/EJE-21-1208.
    PubMed     Abstract available
    
    
    
30. WAGUESPACK SG, Drilon A, Lin JJ, Brose MS, et al
    Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1259. doi: 10.1530/EJE-21-1259.
    PubMed     Abstract available
    
    
    February 2022
31. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Sex differences in MEN 2A penetrance and expression according to parental inheritance.
    Eur J Endocrinol. 2022;186:469-476.
    PubMed     Abstract available
    
    
    
32. KOSTEV K
    Frequency of over- and under-treatment with levothyroxine in primary care in Germany.
    Eur J Endocrinol. 2022;186:L5.
    PubMed    
    
    
    
33. BARGAS S, Mc Leer A, Mondet J, Chabre O, et al
    An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0509.R2. doi: 10.1530/EJE-21-0509.
    PubMed     Abstract available
    
    
    
34. WENZEK C, Boelen A, Westendorf AM, Engel DR, et al
    The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-1171. doi: 10.1530/EJE-21-1171.
    PubMed     Abstract available
    
    
    
35. PENG F, Palazzi P, Mezzache S, Bourokba N, et al
    Profiling steroid and thyroid hormones with hair analysis in a cohort of women aged 25 to 45 years old.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-22-0081. doi: 10.1530/EJE-22-0081.
    PubMed     Abstract available
    
    
    January 2022
36. VAN VELSEN EFS, Peeters RP, Stegenga MT, Mader U, et al
    Evaluating the Use of a Two-step Age-based Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-1056.R1. doi: 10.1530/EJE-21-1056.
    PubMed     Abstract available
    
    
    
37. GIANNOULA E, Iakovou I, Giovanella L, Vrachimis A, et al
    Updated clinical management guidance during the COVID-19 Pandemic: Thyroid nodules and cancer.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-0716.R2. doi: 10.1530/EJE-21-0716.
    PubMed     Abstract available
    
    
    December 2021
38. FUJITA N, Ono Y, Sano A, Kimata M, et al
    Serum diiodotyrosine-a biomarker to differentiate destructive thyroiditis from Graves' disease.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0901.R1. doi: 10.1530/EJE-21-0901.
    PubMed     Abstract available
    
    
    
39. WEBER T, Powlawski A, Vorlander C, Dotzenrath C, et al
    Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-1015.R1. doi: 10.1530/EJE-21-1015.
    PubMed     Abstract available
    
    
    November 2021
40. SEEJORE K, Giannoudi M, Osborn D, Lynch JM, et al
    Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0760.R1. doi: 10.1530/EJE-21-0760.
    PubMed     Abstract available
    
    
    
41. ALONSO SP, Valdes S, Maldonado-Araque C, Lago A, et al
    Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0640.R2. doi: 10.1530/EJE-21-0640.
    PubMed     Abstract available
    
    
    
42. OKAZAKI-HADA M, Nishihara E, Hisakado M, Kudo T, et al
    Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0584.R3. doi: 10.1530/EJE-21-0584.
    PubMed     Abstract available
    
    
    
43. XIAO J, Zhang Y, Yan L, Zhang M, et al
    Ultrasonography-guided Radiofrequency Ablation for Solitary T1aN0M0 and T1bN0M0 Papillary Thyroid Carcinoma: A Retrospective Comparative Study.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0580.R1. doi: 10.1530/EJE-21-0580.
    PubMed     Abstract available
    
    
    
44. MACIEL RMB, Maia AL
    Geographical Variation in the profile of RET Variants in Patients with Medullary Thyroid Cancer: A Comprehensive Review.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0753.R1. doi: 10.1530/EJE-21-0753.
    PubMed     Abstract available
    
    
    
45. LI Y, Shan Z, Teng W
    Effect of the transition from more than adequate iodine to adequate iodine on national changes in the prevalence of thyroid disorders: Repeat national cross-sectional surveys in China.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0975.R1. doi: 10.1530/EJE-21-0975.
    PubMed     Abstract available
    
    
    October 2021
46. SMITH TJ
    Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy.
    Eur J Endocrinol. 2021;185:L13-L14.
    PubMed    
    
    
    
47. KAHALY GJ, Bartalena L
    Response to comment by Smith on the 2021 EUGOGO guidelines.
    Eur J Endocrinol. 2021;185:L15-L16.
    PubMed    
    
    
    
48. VIGONE MC, Ortolano R, Vincenzi G, Pozzi C, et al
    Treatment of Congenital Hypothyroidism: Comparison Between L-Thyroxine Oral Solution and Tablet Formulations up to 3 years of age.
    Eur J Endocrinol. 2021 Oct 1. pii: EJE-20-1444.R2. doi: 10.1530/EJE-20-1444.
    PubMed     Abstract available
    
    
    September 2021
49. LA COUR JL, Medici BR, Grand MK, Nicolaisdottir DR, et al
    Risk of over- and undertreatment with levothyroxine in primary care in Copenhagen, Denmark.
    Eur J Endocrinol. 2021 Sep 1. pii: EJE-21-0485.R1. doi: 10.1530/EJE-21-0485.
    PubMed     Abstract available
    
    
    
50. NOLAN J, Campbell PJ, Brown SJ, Zhu G, et al
    Genome-wide analysis of thyroid function in Australian adolescents highlights SERPINA7 and NCOA3.
    Eur J Endocrinol. 2021 Sep 1. pii: EJE-21-0614.R1. doi: 10.1530/EJE-21-0614.
    PubMed     Abstract available
    
    
    
51. KIM HJ, Park SJ, Park HK, Byun DW, et al
    Thyroid Autoimmunity and Metabolic Syndrome: A Nationwide Population-Based Study.
    Eur J Endocrinol. 2021 Sep 1. pii: EJE-21-0634.R2. doi: 10.1530/EJE-21-0634.
    PubMed     Abstract available
    
    
    
52. NIES M, Arts EGJM, van Velsen EFS, Burgerhof JG, et al
    Long-term Male Fertility after Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
    Eur J Endocrinol. 2021 Sep 1. pii: EJE-21-0315.R2. doi: 10.1530/EJE-21-0315.
    PubMed     Abstract available
    
    
    August 2021
53. BARTALENA L, Kahaly GJ, Baldeschi L, Dayan CM, et al
    The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Eur J Endocrinol. 2021;185:G43-G67.
    PubMed     Abstract available
    
    
    
54. SUN L, Goh HJ, Verma S, Govindharajulu P, et al
    Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism.
    Eur J Endocrinol. 2021 Aug 1. pii: EJE-21-0366.R1. doi: 10.1530/EJE-21-0366.
    PubMed     Abstract available
    
    
    July 2021
55. DE HERDT C, Philipse E, De Block C
    ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    Eur J Endocrinol. 2021;185:R65-R74.
    PubMed     Abstract available
    
    
    
56. HOERMANN R, Midgley JEM, Larisch R, Dietrich JW, et al
    Response: Subclinical hypothyroidism: To treat or not to treat. Eur J Endocrinol. 2020;183:D15-D24. doi:10.1530/EJE-20-0621.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-20-1405. doi: 10.1530/EJE-20-1405.
    PubMed     Abstract available
    
    
    
57. VAN VELSEN EFS, Peeters RP, Stegenga MT, van Kemenade FJ, et al
    The Influence of Age on Disease Outcome in 2015 ATA High Risk Differentiated Thyroid Cancer Patients.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-21-0365.R2. doi: 10.1530/EJE-21-0365.
    PubMed     Abstract available
    
    
    
58. CAMPENNI A, Ruggeri RM, Siracusa M, Giacoppo G, et al
    ISTHMUS TOPOGRAPHY IS A RISK FACTOR FOR PERSISTENT DISEASE IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-21-0328.R1. doi: 10.1530/EJE-21-0328.
    PubMed     Abstract available
    
    
    
59. GIORDANO D, Botti C, Piana S, Zini M, et al
    Postoperative Hypoparathyroidism after Completion Thyroidectomy for Well-Differentiated Thyroid Cancer.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-21-0353.R2. doi: 10.1530/EJE-21-0353.
    PubMed     Abstract available
    
    
    
60. MOUTZOURI E, Lyko C, Feller M, Blum MR, et al
    Subclinical Thyroid Function and Cardiovascular Events in patients with Atrial Fibrillation.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-20-1442.R4. doi: 10.1530/EJE-20-1442.
    PubMed     Abstract available
    
    
    
61. KIEL S, Ittermann T, Steinbach J, Volzke H, et al
    The course of thyroid nodules and thyroid volume over a time-period of up to 10 years: a longitudinal analysis of a population-based cohort.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-21-0610.R1. doi: 10.1530/EJE-21-0610.
    PubMed     Abstract available
    
    
    
62. BAYONA A, Benavent P, Muriel A, Abuchaibe C, et al
    Outcomes of Repeat Fine Needle Aspiration Biopsy for AUS/FLUS Thyroid Nodules. A Systematic Review and Meta-Analysis.
    Eur J Endocrinol. 2021 Jul 1. pii: EJE-21-0330.R1. doi: 10.1530/EJE-21-0330.
    PubMed     Abstract available
    
    
    June 2021
63. VAN LIESHOUT JM, Mooij CF, van Trotsenburg ASP, Zwaveling-Soonawala N, et al
    Methimazole-Induced Remission Rates in Pediatric Graves' Disease: a Systematic Review.
    Eur J Endocrinol. 2021 Jun 1. pii: EJE-21-0077.R1. doi: 10.1530/EJE-21-0077.
    PubMed     Abstract available
    
    
    
64. MERCHAN RAMIREZ E, Sanchez-Delgado G, Arrizabalaga-Arriazu C, Martinez-Tellez B, et al
    Thyroid function is not associated with brown adipose tissue volume and 18F-Fluorodeoxyglucose uptake in young euthyroid adults.
    Eur J Endocrinol. 2021 Jun 1. pii: EJE-21-0192.R2. doi: 10.1530/EJE-21-0192.
    PubMed     Abstract available
    
    
    May 2021
65. SUZUKI S, Matsuo K, Ito Y, Kobayashi A, et al
    A mutation of the beta-domain in POU1F1 causes pituitary deficiency due to dominant PIT-1beta expression.
    Eur J Endocrinol. 2021;185:1-12.
    PubMed     Abstract available
    
    
    
66. MATRONE A, Gambale C, Biagini M, Prete A, et al
    Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0313.R2. doi: 10.1530/EJE-21-0313.
    PubMed     Abstract available
    
    
    
67. MOLINARO E, Campopiano MC, Elisei R
    Management of endocrine disease: Papillary thyroid microcarcinoma: towards an active surveillance strategy.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0256.R1. doi: 10.1530/EJE-21-0256.
    PubMed     Abstract available
    
    
    
68. ROTONDI M, Molteni M, Cappelli C, Croce L, et al
    The diagnostic accuracy of fine-needle aspiration cytology for thyroid nodules is not affected by coexistent chronic autoimmune thyroiditis: Results from a cyto-histological series of patients with indeterminate cytology.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0094.R1. doi: 10.1530/EJE-21-0094.
    PubMed     Abstract available
    
    
    April 2021
69. KONG Y, Bu R, Parvathareddy SK, K Siraj A, et al
    NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC.
    Eur J Endocrinol. 2021;184:503-511.
    PubMed     Abstract available
    
    
    
70. YE X, Zhao H, Liu J, Lu B, et al
    Retraction: Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
    Eur J Endocrinol. 2021;184:Z1.
    PubMed    
    
    
    
71. LAMARTINA L, Bidault S, Hadoux J, Guerlain J, et al
    Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0091.R1. doi: 10.1530/EJE-21-0091.
    PubMed     Abstract available
    
    
    
72. PARK J, Jung HA, Shim JH, Park WY, et al
    Multimodal Treatments and Outcomes for Anaplastic Thyroid Cancer Before and After Tyrosine Kinase Inhibitor Therapy: A Real-World Experience.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-1482.R2. doi: 10.1530/EJE-20-1482.
    PubMed     Abstract available
    
    
    March 2021
73. SAIE C, Wassermann J, Mathy E, Chereau N, et al
    Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients.
    Eur J Endocrinol. 2021 Mar 1. pii: EJE-20-1073.R3. doi: 10.1530/EJE-20-1073.
    PubMed     Abstract available
    
    
    
74. ROZENBAUM A, Buffet C, Bigorgne C, Royer B, et al
    Outcomes of active surveillance of EU-TIRADS 5 thyroid nodules.
    Eur J Endocrinol. 2021 Mar 1. pii: EJE-20-1481.R1. doi: 10.1530/EJE-20-1481.
    PubMed     Abstract available
    
    
    
75. CAMPI I, Bulgarelli I, Dubini A, Perego GB, et al
    THE SPECTRUM OF THYROID FUNCTION TESTS DURING HOSPITALIZATION FOR SARS COV-2 INFECTION.
    Eur J Endocrinol. 2021 Mar 1. pii: EJE-20-1391.R3. doi: 10.1530/EJE-20-1391.
    PubMed     Abstract available
    
    
    
76. VAN KINSCHOT CMJ, Soekhai VR, de Bekker-Grob EW, Visser WE, et al
    Patients' and clinicians' preferences for treatment for Graves' disease: A discrete choice experiment.
    Eur J Endocrinol. 2021 Mar 1. pii: EJE-20-1490.R1. doi: 10.1530/EJE-20-1490.
    PubMed     Abstract available
    
    
    February 2021
77. YE X, Zhao H, Liu J, Lu B, et al
    Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
    Eur J Endocrinol. 2021;184:277-287.
    PubMed     Abstract available
    
    
    
78. RICHMAN DM, Cherella CE, Smith JR, Modi BP, et al
    Clinical Utility of Sonographic Features in Indeterminate Pediatric Thyroid Nodules.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1480.R1. doi: 10.1530/EJE-20-1480.
    PubMed     Abstract available
    
    
    January 2021
79. NAZERI P, Shariat M, Azizi F
    Effects of iodine supplementation during pregnancy on pregnant women and their offspring: a systematic review and meta-analysis of trials over the past 3 decades.
    Eur J Endocrinol. 2021;184:91-106.
    PubMed     Abstract available
    
    
    
80. FALLAHI P, Ferrari SM, Elia G, Ragusa F, et al
    THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors.
    Eur J Endocrinol. 2021;184:R29-R40.
    PubMed     Abstract available
    
    
    
81. KRASHIN E, Silverman B, Steinberg DM, Yekutieli D, et al
    Opposing effects of thyroid hormones on cancer risk: A population-based study.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-1123.R1. doi: 10.1530/EJE-20-1123.
    PubMed     Abstract available
    
    
    
82. BENLARBI H, Simon D, Rosenblatt J, Dumeine C, et al
    Prevalence and course of thyroid dysfunction in neonates at high risk of Graves' disease or with non-autoimmune hyperthyroidism.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-1320.R1. doi: 10.1530/EJE-20-1320.
    PubMed     Abstract available
    
    
    
83. POPPE KG
    Management of endocrine disease: Thyroid and Female Infertility:More Questions than Answers?!
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-1284.R1. doi: 10.1530/EJE-20-1284.
    PubMed     Abstract available
    
    
    December 2020
84. ELEFTHERIADOU AM, Mehl S, Renko K, Kasim RH, et al
    Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease.
    Eur J Endocrinol. 2020;183:571-580.
    PubMed     Abstract available
    
    
    
85. GIANNETTA E, Guarnotta V, Altieri B, Sciammarella C, et al
    ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus.
    Eur J Endocrinol. 2020;183:R197-R215.
    PubMed     Abstract available
    
    
    
86. PEETERS RP, Brito JP
    Subclinical hypothyroidism: to treat or not to treat?
    Eur J Endocrinol. 2020;183:D15-D24.
    PubMed     Abstract available
    
    
    
87. WOOD CL, Cole M, Donaldson M, Dunger DB, et al
    Randomised trial of block and replace vs dose titration thionamide in young people with thyrotoxicosis.
    Eur J Endocrinol. 2020;183:637-645.
    PubMed     Abstract available
    
    
    
88. NAAFS JC, Verkerk PH, Fliers E, van Trotsenburg ASP, et al
    Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening.
    Eur J Endocrinol. 2020;183:627-636.
    PubMed     Abstract available
    
    
    
89. HOI-YEE LI G, Cheung CL, Zhao SX, Song HD, et al
    Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis.
    Eur J Endocrinol. 2020;183:607-617.
    PubMed     Abstract available
    
    
    
90. SANTANA NO, Lerario AM, Schmerling CK, Marui S, et al
    Molecular profile of Hurthle cell carcinomas: recurrent mutations in the Wnt/beta-catenin pathway.
    Eur J Endocrinol. 2020;183:647-656.
    PubMed     Abstract available
    
    
    
91. PERROS P, Nirantharakumar K, Hegedus L
    Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death.
    Eur J Endocrinol. 2020 Dec 1. pii: EJE-20-1229.R1. doi: 10.1530/EJE-20-1229.
    PubMed     Abstract available
    
    
    November 2020
92. DEANDREA M, Trimboli P, Creanza A, Garino F, et al
    Long-term follow-up of cystic thyroid nodules treated with percutaneous ethanol injection (PEI) using two different approaches.
    Eur J Endocrinol. 2020;183:489-495.
    PubMed     Abstract available
    
    
    October 2020
93. VAN WELIE N, Portela M, Dreyer K, Schoonmade LJ, et al
    Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0627.R1. doi: 10.1530/EJE-20-0627.
    PubMed     Abstract available
    
    
    
94. KIM M, Kim BH, Lee H, Nam H, et al
    Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0686.R1. doi: 10.1530/EJE-20-0686.
    PubMed     Abstract available
    
    
    
95. JIN H, Lin W, Lu L, Cui M, et al
    Conventional thyroidectomy versus thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0562.R1. doi: 10.1530/EJE-20-0562.
    PubMed     Abstract available
    
    
    
96. ILLOUZ F, Chanson P, Sonnet E, Brue T, et al
    Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0484.R2. doi: 10.1530/EJE-20-0484.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: